EUVIMEDEUVIMED entdecken
Crossref

Spherical Crystal Agglomeration Technique for Improved Flow Properties and Oral Bioavailability of Atazanavir Sulphate

Darpan Shah, Jatin Rawat, Hetal Thakkar iD

Therapeutic Delivery · 2023

DOI: 10.4155/tde-2022-0063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Delivery, 2023. Verfasst von Darpan Shah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Post-Graduate Studies & Research in Pharmaceutical Sciences, Shri GH Patel Pharmacy building, Faculty of Pharmacy, The Maharaja Sayajirao …. Hauptthemen laut MEDLINE: Atazanavir Sulfate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atazanavir SulfateBiological AvailabilitySolubilityDrug LiberationSolventsTabletsAdministration, Oral

Stichwörter der Autor:innen

HIV• oral drug delivery systematazanavir sulfatedirect compressionspherical crystal agglomeration

Substanzen

Atazanavir SulfateSolventsTablets

Autor:innen und Institutionen

  • Center for Post-Graduate Studies & Research in Pharmaceutical Sciences, Shri GH Patel Pharmacy building, Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, 390002, India.

ORCID-Profile: Hetal Thakkar

Zitieren

APA

Shah, D., Rawat, J., & Thakkar, H. (2023). Spherical Crystal Agglomeration Technique for Improved Flow Properties and Oral Bioavailability of Atazanavir Sulphate. Therapeutic Delivery. https://doi.org/10.4155/tde-2022-0063

Vancouver

Shah D, Rawat J, Thakkar H. Spherical Crystal Agglomeration Technique for Improved Flow Properties and Oral Bioavailability of Atazanavir Sulphate. Therapeutic Delivery. 2023. doi:10.4155/tde-2022-0063

BibTeX
@article{Shah2023,
  author = {Shah, Darpan and Rawat, Jatin and Thakkar, Hetal},
  title = {Spherical Crystal Agglomeration Technique for Improved Flow Properties and Oral Bioavailability of Atazanavir Sulphate},
  journal = {Therapeutic Delivery},
  year = {2023},
  doi = {10.4155/tde-2022-0063}
}
Kostenlos starten →